Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
Type de publicationJournal Article
Year of Publication2015
AuteursRodon P, Hulin C, Pegourie B, Tiab M, Anglaret B, Benboubker L, Jardel H, Decaux O, Kolb B, Roussel M, Garderet L, Leleu X, Fitoussi O, Chaleteix C, Casassus P, Lenain P, Royer B, Banos A, Benramdane R, Cony-Makhoul P, Dib M, Fontan J, Stoppa A-M, Traulle C, Vilque J-P, Petillon M-O, Mathiot C, Dejoie T, Avet-Loiseau H, Moreau P
JournalHAEMATOLOGICA
Volume100
PaginationE56-E59
Date PublishedFEB
Type of ArticleLetter
ISSN0390-6078
Mots-clésbendamustine, Elderly, Multiple myeloma, relapse
DOI10.3324/haematol.2014.110890